CME Group Inc. (NASDAQ:CME) Shares Sold by MRP Capital Investments LLC

MRP Capital Investments LLC trimmed its holdings in CME Group Inc. (NASDAQ:CME - Free Report) by 50.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,955 shares of the financial services provider's stock after selling 5,096 shares during the quarter. MRP Capital Investments LLC's holdings in CME Group were worth $1,044,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the company. ORG Partners LLC raised its position in CME Group by 201.7% during the 4th quarter. ORG Partners LLC now owns 362 shares of the financial services provider's stock worth $76,000 after buying an additional 242 shares during the last quarter. NewEdge Wealth LLC raised its position in CME Group by 11.4% during the 4th quarter. NewEdge Wealth LLC now owns 9,746 shares of the financial services provider's stock worth $2,053,000 after buying an additional 996 shares during the last quarter. Highview Capital Management LLC DE raised its position in CME Group by 7.7% during the 4th quarter. Highview Capital Management LLC DE now owns 8,793 shares of the financial services provider's stock worth $1,852,000 after buying an additional 630 shares during the last quarter. Genesee Capital Advisors LLC purchased a new position in CME Group during the 4th quarter worth $787,000. Finally, Clarus Group Inc. purchased a new position in CME Group during the 4th quarter worth $323,000. 87.75% of the stock is owned by institutional investors and hedge funds.

CME Group Trading Down 1.5 %

Shares of CME stock traded down $3.27 during trading hours on Friday, hitting $209.50. 1,582,600 shares of the company were exchanged, compared to its average volume of 1,778,035. The firm has a market cap of $75.42 billion, a PE ratio of 23.62, a PEG ratio of 6.02 and a beta of 0.49. CME Group Inc. has a 1 year low of $175.73 and a 1 year high of $223.80. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The firm has a fifty day moving average of $213.98 and a 200 day moving average of $211.41.

CME Group (NASDAQ:CME - Get Free Report) last announced its quarterly earnings data on Wednesday, February 14th. The financial services provider reported $2.37 earnings per share for the quarter, topping the consensus estimate of $2.27 by $0.10. The business had revenue of $1.44 billion for the quarter, compared to analyst estimates of $1.43 billion. CME Group had a net margin of 57.83% and a return on equity of 12.32%. The company's revenue was up 19.2% on a year-over-year basis. During the same period in the prior year, the firm posted $1.92 EPS. Analysts expect that CME Group Inc. will post 9.56 earnings per share for the current year.

CME Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 26th. Investors of record on Friday, March 8th were issued a $1.15 dividend. This is a positive change from CME Group's previous quarterly dividend of $1.10. The ex-dividend date was Thursday, March 7th. This represents a $4.60 annualized dividend and a yield of 2.20%. CME Group's dividend payout ratio (DPR) is presently 51.86%.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on CME shares. The Goldman Sachs Group cut shares of CME Group from a "neutral" rating to a "sell" rating and set a $195.00 price target on the stock. in a research note on Wednesday, January 3rd. Morgan Stanley upped their price target on shares of CME Group from $222.00 to $225.00 and gave the stock an "equal weight" rating in a research note on Tuesday. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating and set a $210.00 price target (down from $235.00) on shares of CME Group in a research note on Friday, April 5th. Barclays upped their price target on shares of CME Group from $225.00 to $226.00 and gave the stock an "equal weight" rating in a research note on Monday. Finally, Argus upped their price target on shares of CME Group from $225.00 to $245.00 and gave the stock a "buy" rating in a research note on Wednesday, March 6th. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $216.18.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.